# FDA Inspection 1181652 - Biomat USA Inc - October 13, 2022

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c8ab1eda-1fd6-49cc-b8b2-dc29a27abe10
Source feed: FDA_Inspections

> FDA Inspection 1181652 for Biomat USA Inc on October 13, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181652
- Company Name: Biomat USA Inc
- Inspection Date: 2022-10-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1181652 - 2022-10-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c380b1d9-0952-442d-ba72-8a079b1ced14)

Company: https://www.keypedia.com/companies/biomat-usa-inc/71902ec2-ed88-4a0f-a038-7bd2c27584d3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d